/EXCL

EXCL Stock - Excellerant, Inc.

Q: What is the analyst price target for EXCL?

Analyst price target information is not currently available for EXCL.

Q: What is EXCL's market cap?

Market capitalization information is not currently available for EXCL.

Financial Services|Shell Companies|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for EXCL

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2019

FY2020

FY2021

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta2.01

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2021	FY2020	FY2019
Revenue	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A
Gross Margin	N/A	N/A	N/A
Operating Income	$-13,800	$-21,844	$-11,023
Net Income	$-13,800	$-21,844	$-11,023
Net Margin	N/A	N/A	N/A
EPS	$-0.01	$-0.00	$-0.00

Company Overview

Excellerant, Inc., a development stage company, focuses on providing a range of health advisory and tour services to legal entities and individuals. The company intends to offer consulting services in the field of traditional and alternative medicine, and medical technologies; for customers to choose a clinic for treatment, as well as arrange the itinerary by building a route, which includes clinics, hospitals, and other medical institutions; and providing guide services to potential clients. Further, it provides information related to transportation and medical institutions. The company was incorporated in 2019 and is based in Brussels, Belgium. Excellerant, Inc. is a subsidiary of Swamson Capital AG.

Visit Website

Frequently Asked Questions about EXCL

What is EXCL's current stock price?

Excellerant, Inc. (EXCL) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for EXCL?

No analyst price targets are currently available for this stock.

What sector is Excellerant, Inc. in?

Excellerant, Inc. operates in the Financial Services sector, specifically within the Shell Companies industry. The company is traded on the OTC exchange.

What is EXCL's market cap?

Excellerant, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does EXCL pay dividends?

No, Excellerant, Inc. does not currently pay a dividend to shareholders.